Western Blotting Market is estimated to be valued at USD 927.6 Mn in 2026 and is expected to reach USD 1,489.5 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 7.0% from 2026 to 2033.
Analysts’ Views on Global Western Blotting Market:
Use of western blotting for medical diagnosis is expected to drive the global western blotting market over the forecast period. For instance, in April 2021, according to National Center for Biotechnology Information (NCBI), western blotting has been widely used in disease diagnosis mostly for the detection of HIV.
Figure 1. Global Western Blotting Market Share (%), by Application, 2026

To learn more about this report, Download Free Sample
Global Western Blotting Market – Driver
Increasing prevalence of HIV
Increasing prevalence of HIV is expected to drive the global western blotting market over the forecast period as western blotting is mostly used for detection of HIV. For instance, in January 2022, according to data published by UNAIDS, a Joint United Nations Programme which is involved in data collection on HIV epidemiology, 1.5 million people became newly infected with HIV in 2021.
Figure 2. Global Western Blotting Market Value (US$ Million), by Region, 2026

To learn more about this report, Download Free Sample
Global Western Blotting Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global western blotting market over the forecast period. North America holds 45.1% of the market share due to the increasing prevalence of HIV in the region. For instance, in October 2026, according to the U.S. Department of Health & Human Services, approximately 1.2 million people in the U.S. have HIV and about 13 % of them don’t know if they are suffering from HIV and need testing.
For instance, in December 2020, Science Direct, a scientific journal, stated that Western blots were used to identifyantigensvaccine.
Global Western Blotting Market Segmentation:
The global western blotting market report is segmented into product type, application, end user, and region
Based on Product Type, the market is segmented into electrophoresis blotting systems (automated dry blotting systems, semi-dry blotting systems, traditional wet transfer blotting systems), reagents & kits (chromogenic reagents kits, chemiluminescent reagents kits)(horseradish peroxidase (hrp) substrate, alkaline phosphatase (ap) substrate), fluorescent reagents, antibodies(primary antibody, secondary antibody), buffer kits, transfer membranes). Out of which, the electrophoresis blotting systems segment is expected to hold a dominant position in the western blotting market during the forecast period and this is attributed to the increasing usage of electrophoresis blotting systems for the diagnosis of diseases.
Based on Application, the market is segmented into scientific research, medical diagnostics, agricultural application, food & beverages, and other applications. Out of which, the medical diagnostics segment is expected to hold a dominant position in the western blotting market during the forecast period and this is attributed to the increasing prevalence of HIV.
Based on End User, the market is segmented into diagnostic laboratories, research institutions, and pharmaceutical & biotechnology companies. Out of which, diagnostic laboratories is expected to dominate the market over the forecast period and this is attributed to the increase in the number of diagnoses for the identification of infections like HIV.
Among all segmentation, the application segment has the highest potential due to the increasing prevalence of HIV over the forecast period. For instance, in 2022, according to data published by the Centers for Disease Control and Prevention (CDC), stated that in 2020, 30,635 people received an HIV diagnosis in the U.S.
Western Blotting Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 927.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.0% | 2033 Value Projection: | USD 1,489.5 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Global Western Blotting Market Cross Sectional Analysis:
In application segment, medical diagnostics hold a dominant segment in North America region due to the increasing prevalence of HIV and hepatitis C. For instance, in August 2022, according to the Centers for Disease Control and Prevention (CDC), there were 107,300 cases of newly reported chronic hepatitis C in 2020.
Global Western Blotting Market: Key Developments
Global Western Blotting Market: Key Trends
Increasing applications of western blotting technique
Increasing applications of western blotting technique is expected to drive the western blotting market growth over the forecast period. For instance, in January 2020, researchers at British Antarctic Survey, Natural Environment Research Council, U.K., reported the use of western blotting in the assessment of post-translationally deiminated protein and EV profiles of plasma in seabird species from the Antarctic.
Global Western Blotting Market: Restraint
Disadvantages associated with western blotting
The global western blotting market can be hindered by disadvantages associated with western blotting. For instance, in April 2022, a report published by National Center for Biotechnology Information (NCBI), stated that disadvantages of western blotting such as poor membrane blocking, excessive antibody concentration, and a dry membrane can result in high background signals.
Global Western Blotting Market - Key Players
Major players operating in the global western blotting market include Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., and Leinco Technologies
*Defination- Western blot is often used in research to separate and identify proteins. In this technique a mixture of proteins is separated based on molecular weight, and thus by type, through gel electrophoresis. These results are then transferred to a membrane producing a band for each protein.
Share
Share
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients